English
简体中文
Total: £ 56.28
Published Date: 2025-03-25 | Pages: 68 | Tables: 68 | Pharma & Healthcare
The global market for Ranibizumab was valued at US$ 2805 million in the year 2024 and is projected to reach a revised size of US$ 1367 million by 2031, growing at a CAGR of -9.9% during the forecast period.
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.
The ranibizumab market is primarily driven by the increasing prevalence of eye diseases such as age-related macular degeneration (AMD), diabetic retinopathy, and macular edema. As the global population ages and diabetes rates rise, the demand for effective treatments like ranibizumab continues to grow. Ranibizumab, an anti-VEGF (vascular endothelial growth factor) therapy, has proven highly effective in reducing vision loss and improving patient outcomes. Additionally, advancements in drug delivery methods, along with expanding healthcare access in emerging markets, are supporting the growth of the ranibizumab market.
One of the key challenges in the ranibizumab market is the high cost of the drug, which can limit patient access, particularly in developing countries or among uninsured populations. While biosimilar versions are being developed, affordability remains a concern. Additionally, there is growing competition from alternative therapies and biosimilars that offer similar efficacy at a lower price. Patient adherence to treatment regimens, which often require frequent intravitreal injections, can also be a challenge, as some patients may find the process uncomfortable or inconvenient.
Global core ranibizumab manufacturers include Roche and Novartis etc. The Top 2 companies hold a share about 98%. North America is the largest market, with a share about 51%, followed by Europe and Asia Pacific with the share about 28% and 20%.
This report aims to provide a comprehensive presentation of the global market for Ranibizumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ranibizumab.
The Ranibizumab market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ranibizumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ranibizumab companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Coherus
Biogen
Segment by Type
Glass Vial
Prefilled Syringe
Segment by Application
Wet AMD
Complications of Diabetes
RVO
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ranibizumab company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ranibizumab Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Glass Vial
1.2.3 Prefilled Syringe
1.3 Market by Application
1.3.1 Global Ranibizumab Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Wet AMD
1.3.3 Complications of Diabetes
1.3.4 RVO
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ranibizumab Market Perspective (2020-2031)
2.2 Global Ranibizumab Growth Trends by Region
2.2.1 Global Ranibizumab Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Ranibizumab Historic Market Size by Region (2020-2025)
2.2.3 Ranibizumab Forecasted Market Size by Region (2026-2031)
2.3 Ranibizumab Market Dynamics
2.3.1 Ranibizumab Industry Trends
2.3.2 Ranibizumab Market Drivers
2.3.3 Ranibizumab Market Challenges
2.3.4 Ranibizumab Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ranibizumab Players by Revenue
3.1.1 Global Top Ranibizumab Players by Revenue (2020-2025)
3.1.2 Global Ranibizumab Revenue Market Share by Players (2020-2025)
3.2 Global Ranibizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Ranibizumab Revenue
3.4 Global Ranibizumab Market Concentration Ratio
3.4.1 Global Ranibizumab Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ranibizumab Revenue in 2024
3.5 Global Key Players of Ranibizumab Head office and Area Served
3.6 Global Key Players of Ranibizumab, Product and Application
3.7 Global Key Players of Ranibizumab, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ranibizumab Breakdown Data by Type
4.1 Global Ranibizumab Historic Market Size by Type (2020-2025)
4.2 Global Ranibizumab Forecasted Market Size by Type (2026-2031)
5 Ranibizumab Breakdown Data by Application
5.1 Global Ranibizumab Historic Market Size by Application (2020-2025)
5.2 Global Ranibizumab Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Ranibizumab Market Size (2020-2031)
6.2 North America Ranibizumab Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Ranibizumab Market Size by Country (2020-2025)
6.4 North America Ranibizumab Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ranibizumab Market Size (2020-2031)
7.2 Europe Ranibizumab Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Ranibizumab Market Size by Country (2020-2025)
7.4 Europe Ranibizumab Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ranibizumab Market Size (2020-2031)
8.2 Asia-Pacific Ranibizumab Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Ranibizumab Market Size by Region (2020-2025)
8.4 Asia-Pacific Ranibizumab Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ranibizumab Market Size (2020-2031)
9.2 Latin America Ranibizumab Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Ranibizumab Market Size by Country (2020-2025)
9.4 Latin America Ranibizumab Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ranibizumab Market Size (2020-2031)
10.2 Middle East & Africa Ranibizumab Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Ranibizumab Market Size by Country (2020-2025)
10.4 Middle East & Africa Ranibizumab Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Ranibizumab Introduction
11.1.4 Roche Revenue in Ranibizumab Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Coherus
11.2.1 Coherus Company Details
11.2.2 Coherus Business Overview
11.2.3 Coherus Ranibizumab Introduction
11.2.4 Coherus Revenue in Ranibizumab Business (2020-2025)
11.2.5 Coherus Recent Development
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Ranibizumab Introduction
11.3.4 Biogen Revenue in Ranibizumab Business (2020-2025)
11.3.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Ranibizumab Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Glass Vial
Table 3. Key Players of Prefilled Syringe
Table 4. Global Ranibizumab Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Ranibizumab Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Ranibizumab Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Ranibizumab Market Share by Region (2020-2025)
Table 8. Global Ranibizumab Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Ranibizumab Market Share by Region (2026-2031)
Table 10. Ranibizumab Market Trends
Table 11. Ranibizumab Market Drivers
Table 12. Ranibizumab Market Challenges
Table 13. Ranibizumab Market Restraints
Table 14. Global Ranibizumab Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Ranibizumab Market Share by Players (2020-2025)
Table 16. Global Top Ranibizumab Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ranibizumab as of 2024)
Table 17. Ranking of Global Top Ranibizumab Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Ranibizumab Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Ranibizumab, Headquarters and Area Served
Table 20. Global Key Players of Ranibizumab, Product and Application
Table 21. Global Key Players of Ranibizumab, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ranibizumab Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Ranibizumab Revenue Market Share by Type (2020-2025)
Table 25. Global Ranibizumab Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Ranibizumab Revenue Market Share by Type (2026-2031)
Table 27. Global Ranibizumab Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Ranibizumab Revenue Market Share by Application (2020-2025)
Table 29. Global Ranibizumab Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Ranibizumab Revenue Market Share by Application (2026-2031)
Table 31. North America Ranibizumab Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Ranibizumab Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Ranibizumab Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Ranibizumab Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Ranibizumab Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Ranibizumab Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Ranibizumab Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Ranibizumab Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Ranibizumab Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Ranibizumab Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Ranibizumab Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Ranibizumab Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Ranibizumab Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Ranibizumab Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Ranibizumab Market Size by Country (2026-2031) & (US$ Million)
Table 46. Roche Company Details
Table 47. Roche Business Overview
Table 48. Roche Ranibizumab Product
Table 49. Roche Revenue in Ranibizumab Business (2020-2025) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Coherus Company Details
Table 52. Coherus Business Overview
Table 53. Coherus Ranibizumab Product
Table 54. Coherus Revenue in Ranibizumab Business (2020-2025) & (US$ Million)
Table 55. Coherus Recent Development
Table 56. Biogen Company Details
Table 57. Biogen Business Overview
Table 58. Biogen Ranibizumab Product
Table 59. Biogen Revenue in Ranibizumab Business (2020-2025) & (US$ Million)
Table 60. Biogen Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
Table 64. Authors List of This Report
List of Figures
Figure 1. Ranibizumab Picture
Figure 2. Global Ranibizumab Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Ranibizumab Market Share by Type: 2024 VS 2031
Figure 4. Glass Vial Features
Figure 5. Prefilled Syringe Features
Figure 6. Global Ranibizumab Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Ranibizumab Market Share by Application: 2024 VS 2031
Figure 8. Wet AMD Case Studies
Figure 9. Complications of Diabetes Case Studies
Figure 10. RVO Case Studies
Figure 11. Others Case Studies
Figure 12. Ranibizumab Report Years Considered
Figure 13. Global Ranibizumab Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Ranibizumab Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Ranibizumab Market Share by Region: 2024 VS 2031
Figure 16. Global Ranibizumab Market Share by Players in 2024
Figure 17. Global Top Ranibizumab Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ranibizumab as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Ranibizumab Revenue in 2024
Figure 19. North America Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Ranibizumab Market Share by Country (2020-2031)
Figure 21. United States Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Ranibizumab Market Share by Country (2020-2031)
Figure 25. Germany Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Ranibizumab Market Share by Region (2020-2031)
Figure 33. China Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Ranibizumab Market Share by Country (2020-2031)
Figure 41. Mexico Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Ranibizumab Market Share by Country (2020-2031)
Figure 45. Turkey Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Ranibizumab Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Ranibizumab Business (2020-2025)
Figure 49. Coherus Revenue Growth Rate in Ranibizumab Business (2020-2025)
Figure 50. Biogen Revenue Growth Rate in Ranibizumab Business (2020-2025)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
